跳至主要内容
临床试验/CTRI/2020/07/026504
CTRI/2020/07/026504已完成未知

Comparative effectiveness of oral trihexyphenidyl versus trihexyphenidyl plus clonazepam therapy for the treatment of dystonia in children with dystonic cerebral palsy: An open label, randomized controlled trial. - CAT-DC Trial

All India Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Children aged between 1-18 years
  • 2.Diagnosed as dystonic cerebral palsy

排除标准

  • Patients with one or more of following criterion will be excluded:
  • 1.Received any other medication for dystonia in previous three months
  • 2.Received any of the above two drugs for any other indication in previous three months
  • 3.Presence of significant spasticity (ashworth grade 2 or more)
  • 4.History of allergy to any of the above drugs
  • 5.Genetic or syndromic associations
  • 6.Severe concurrent illness or diseases not associated with cerebral palsy or unstable medical conditions like pneumonia
  • 7.Recent orthopedic surgery/cast/botulinum toxin
  • 8.Caregiver not providing informed consent

研究者

相似试验

Oral drugs for dystonia in children with cerebral... | 临床试验